About
Pressroom
Resources
Get Updates
Issues
Access to Medicines
Funding the Fight
Health Justice
Transparency & Accountability
Blog
Our Impact
Take Action
Do something now
DONATE
Under fire for Truvada U.S. pricing at House hearing, Gilead chief O’Day touts R&D costs, asserts governments patents are void
May 17, 2019 |
Brittany Herrick
Women Who Miscarry Could Be Criminally Investigated Under Georgia’s New Abortion Law
What’s behind PEPFAR’s funding cut threats?
Related Posts
Access to Medicines
New ViiV license with the ...
Our Story
Brian Macharia Joins Healt...
Access to Medicines
South Africa and India’s...